New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 27, 2014
08:21 EDTSQNM, FLDM, PKI, DDXS, WAT, PACB, AFFXMaxim recommends life science tools, diagnostics ahead of earnings
Maxim expects 2014 to be a "great year" for life science tools and diagnostics stocks and recommends buying Affymetrix (AFFX), diaDexus (DDXS), Fluidigm (FLDM), Pacific Biosciences (PACB), PerkinElmer (PKI), Sequenom (SQNM) and Waters (WAT) ahead of the Q4 results. Maxim has a preference for Pacific Biosciences, PerkinElmer and Waters. The firm raised its price target for Fluidigm to $52 from $42 and for Pacific Biosciences to $9 from $8.
News For AFFX;DDXS;FLDM;PACB;PKI;SQNM;WAT From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
July 2, 2015
07:48 EDTFLDMFluidigm, Illumina single cell opportunities compelling, says Leerink
Subscribe for More Information
June 30, 2015
07:56 EDTSQNMACOG opinion on NIPT not as bullish as hoped for Sequenom, says William Blair
Subscribe for More Information
07:03 EDTPKIPerkinElmer price target raised to $60 from $53 at Stifel
Stifel says that PerkinElmer's recent multiple expansion appears to be sustainable, and the firm thinks that the company's operating margin can increase to about 20.5% in 2018, up from about 17.6% in 2014. The firm keeps a Buy rating on the stock.
June 25, 2015
09:27 EDTAFFX, FLDMLeerink life science tools analyst holds an analyst/industry conference call
Life Science Tools and Diagnostics Dan Leonard, along with Dr. Paul Robson and Dr. Peter Kuhn, discuss the demand for Fluidigm's single cell prep products, including the impact to Biomark and the utility of CyTOF on an Analyst/Industry conference call to be held on July 1 at 2 pm.
09:23 EDTWATMedtronic announces resignation of Christopher O'Connell
Medtronic (MDT) announced in a regulatory filing that Christopher J. O’Connell is resigning as the company’s EVP and President, Restorative Therapies Group. The company also announced the appointment of Geoff Martha as the company’s EVP and President, Restorative Therapies Group, effective immediately. The Fly notes that Waters (WAT) this morning named O'Connell as its new president, CEO and member of its Board of Directors, effective in September.
09:15 EDTWATWaters names Christopher O'Connell as CEO, effective in September
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use